L E Hollister. Show Affiliations »
Abstract
Mesh: See more » Alcoholism/drug therapyAmitriptyline/therapeutic useAntidepressive Agents/pharmacologyAntidepressive Agents/therapeutic useAnxiety/drug therapyBarbiturates/therapeutic useBehavior/drug effectsBipolar Disorder/drug therapyCannabis/therapeutic useChlordiazepoxide/therapeutic useClinical Trials as TopicDementia/drug therapyDepression/drug therapyDiazepam/therapeutic useHumansImipramine/therapeutic useLithium/therapeutic useLysergic Acid Diethylamide/therapeutic useMeprobamate/therapeutic useMonoamine Oxidase InhibitorsNiacinamide/therapeutic useNortriptyline/therapeutic useOxazepam/therapeutic usePhenothiazinesPhytotherapyPlacebosProchlorperazine/therapeutic usePsychotic Disorders/drug therapyThioridazine/therapeutic useTranquilizing Agents/therapeutic use
Substances: See more » Antidepressive AgentsBarbituratesMonoamine Oxidase InhibitorsPhenothiazinesPlacebosTranquilizing AgentsAmitriptylineNiacinamideOxazepamChlordiazepoxideLysergic Acid DiethylamideLithiumMeprobamateNortriptylineThioridazineImipramineDiazepamProchlorperazine
Year: 1969 PMID: 4238455 DOI: 10.1002/cpt1969102170
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875